Genetic causes and treatment of isolated growth hormone deficiency—an update
- 17 September 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Endocrinology
- Vol. 6 (10), 562-576
- https://doi.org/10.1038/nrendo.2010.147
Abstract
Isolated growth hormone deficiency is the most common pituitary hormone deficiency and can result from congenital or acquired causes, although the majority of cases are idiopathic with no identifiable etiology. Known genes involved in the genetic etiology of isolated growth hormone deficiency include those that encode growth hormone (GH1), growth-hormone-releasing hormone receptor (GHRHR) and transcription factor SOX3. However, mutations are identified in a relatively small percentage of patients, which suggests that other, yet unidentified, genetic factors are involved. Among the known factors, heterozygous mutations in GH1 remain the most frequent cause of isolated growth hormone deficiency. The identification of mutations has clinical implications for the management of patients with this condition, as individuals with heterozygous GH1 mutations vary in phenotype and can, in some cases, develop additional pituitary hormone deficiencies. Lifelong follow-up of these patients is, therefore, recommended. Further studies in the genetic etiology of isolated growth hormone deficiency will help to elucidate mechanisms implicated in the control of growth and may influence future treatment options. Advances in pharmacogenomics will also optimize the treatment of isolated growth hormone deficiency and other conditions associated with short stature, for which recombinant human growth hormone is a licensed therapy.Keywords
This publication has 138 references indexed in Scilit:
- Mutation Analysis of the Muscarinic Cholinergic Receptor Genes in Isolated Growth Hormone Deficiency Type IBJournal of Clinical Endocrinology & Metabolism, 2009
- Rescue of Pituitary Function in a Mouse Model of Isolated Growth Hormone Deficiency Type II by RNA InterferenceEndocrinology, 2007
- A Long-Acting, Mono-PEGylated Human Growth Hormone Analog Is a Potent Stimulator of Weight Gain and Bone Growth in Hypophysectomized RatsEndocrinology, 2007
- Variability of isolated autosomal dominant GH deficiency (IGHD II): impact of the P89L GH mutation on clinical follow-up and GH secretionActa Endocrinologica, 2005
- Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3Journal of Medical Genetics, 2004
- Variability in anterior pituitary size within members of a family with GH deficiency due to a new splice mutation in the GHRH receptor geneClinical Endocrinology, 2004
- Novel mutations of the growth hormone 1 (GH1) gene disclosed by modulation of the clinical selection criteria for individuals with short statureHuman Mutation, 2003
- The molecular genetics of growth hormone deficiencyHuman Genetics, 1998
- Biologically inactive growth hormone caused by an amino acid substitution.JCI Insight, 1997
- A new mutation causing inherited growth hormone deficiency: a compound heterozygote of a 6.7 kb deletion and a two base deletion in the third exon of the GH-1 geneHuman Molecular Genetics, 1993